BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28078459)

  • 1. Endotherapy in case of relapse of neoplastic Barrett's esophagus after successful initial endoscopic resection.
    Godat S; Caillol F; Autret A; Bories E; Pesenti C; Ratone JP; De Cassan C; Poizat F; Giovannini M
    Surg Endosc; 2017 Sep; 31(9):3703-3710. PubMed ID: 28078459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.
    Caillol F; Godat S; Autret A; Bories E; Pesenti C; Ratone JP; Poizat F; Guiramand J; Delpero JR; Giovannini M
    Surg Endosc; 2016 Dec; 30(12):5410-5418. PubMed ID: 27129553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in patients who have failed endoscopic therapy for dysplastic Barrett's metaplasia or early esophageal cancer.
    Hunt BM; Louie BE; Schembre DB; Bohorfoush AG; Farivar AS; Aye RW
    Ann Thorac Surg; 2013 May; 95(5):1734-40. PubMed ID: 23561804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
    Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
    Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
    Belghazi K; Bergman JJGHM; Pouw RE
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotherapy for superficial adenocarcinoma of the esophagus: an American experience.
    Saligram S; Chennat J; Hu H; Davison JM; Fasanella KE; McGrath K
    Gastrointest Endosc; 2013 Jun; 77(6):872-6. PubMed ID: 23472998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.
    Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ
    Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection for Endoscopic Therapy of Barrett's Esophagus-related Neoplasia.
    Kothari S; Kaul V
    Gastroenterol Clin North Am; 2015 Jun; 44(2):317-35. PubMed ID: 26021197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma.
    Hunt BM; Louie BE; Dunst CM; Lipham JC; Farivar AS; Sharata A; Aye RW
    Dis Esophagus; 2014; 27(4):362-7. PubMed ID: 23795720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up.
    Ramay FH; Cui Q; Greenwald BD
    Gastrointest Endosc; 2017 Oct; 86(4):626-632. PubMed ID: 28235596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
    Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
    Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.